Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease

Corstasis Therapeutics Announces FDA Approval of ENBUMYST<img src=”https://s.w.org/images/core/emoji/16.0.1/72×72/2122.png” alt=”™” class=”wp-smiley”> (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease – NEWSnet – News… as it used to be